Literature DB >> 12891673

Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome.

Gabriele V Ronnett1, Donald Leopold, Xiaohe Cai, Kristen C Hoffbuhr, Linda Moses, Eric P Hoffman, Sakkubai Naidu.   

Abstract

Rett's Syndrome (RTT) is a neurodevelopmental disorder resulting from mutation in the mecp2 gene that encodes methyl CpG binding protein 2, a transcriptional repressor. Because this disease primarily affects neurons, tissue is not available during active disease. We used the olfactory system as a model to investigate abnormalities in neuronal development in RTT, because olfactory receptor neurons (ORNs) are replaced throughout life by ongoing postnatal neurogenesis. Thus, even in the adult, the olfactory epithelium contains neurons at various developmental stages. We obtained biopsies of nasal epithelium containing ORNs from RTT patients and age-matched controls to study the status of the neuronal population using antibodies to stage-specific developmental markers. There were no postprocedure complications. Compared with age-matched controls, there were far fewer mature ORNs, as defined by olfactory marker protein expression, and significantly greater numbers of immature neuron-specific tubulin-positive ORNs present. In RTT biopsies, olfactory marker protein-positive neurons displayed abnormal structure. These results suggest that dysfunction of MeCP2 results in decreased survival of mature ORNs with a compensatory increase in neurogenesis, or a failure of immature neurons to mature. Our study indicates that olfactory biopsies provide a method to study neuronal developmental diseases in adults and children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891673     DOI: 10.1002/ana.10633

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  35 in total

1.  Human nasal olfactory epithelium as a dynamic marker for CNS therapy development.

Authors:  Rita Sattler; Yoko Ayukawa; Luke Coddington; Akira Sawa; David Block; Richard Chipkin; Jeffrey D Rothstein
Journal:  Exp Neurol       Date:  2011-09-16       Impact factor: 5.330

Review 2.  Transcriptional regulation of neurogenesis in the olfactory epithelium.

Authors:  Danette J Nicolay; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2006-05-18       Impact factor: 5.046

Review 3.  [Examination of the sense of smell].

Authors:  T Hummel; A Hähner; M Witt; B N Landis
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

Review 4.  Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network.

Authors:  Michael Ogier; David M Katz
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

5.  Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI.

Authors:  Fritz W Lischka; George Gomez; Karen K Yee; Luba Dankulich-Nagrudny; Leen Lo; Mark E Haskins; Nancy E Rawson
Journal:  J Comp Neurol       Date:  2008-11-20       Impact factor: 3.215

Review 6.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

Review 7.  Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research.

Authors:  Joëlle Lavoie; Akira Sawa; Koko Ishizuka
Journal:  Curr Opin Psychiatry       Date:  2017-05       Impact factor: 4.741

8.  White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations.

Authors:  A Mahmood; G Bibat; A-L Zhan; I Izbudak; L Farage; A Horska; S Mori; S Naidu
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

9.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

10.  MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F function.

Authors:  Alicia L Degano; R Jeroen Pasterkamp; Gabriele V Ronnett
Journal:  Mol Cell Neurosci       Date:  2009-07-21       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.